Market Research Logo

Ligand Pharmaceuticals, Inc. - Product Pipeline Review - 2016

Ligand Pharmaceuticals, Inc. - Product Pipeline Review - 2016

Summary

Global Markets Direct’s, ‘Ligand Pharmaceuticals, Inc. - Product Pipeline Review - 2016’, provides an overview of the Ligand Pharmaceuticals, Inc.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Ligand Pharmaceuticals, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of Ligand Pharmaceuticals, Inc.
  • The report provides overview of Ligand Pharmaceuticals, Inc. including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Ligand Pharmaceuticals, Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Ligand Pharmaceuticals, Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
  • Evaluate Ligand Pharmaceuticals, Inc.’s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Ligand Pharmaceuticals, Inc.
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Ligand Pharmaceuticals, Inc.’s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


Ligand Pharmaceuticals, Inc. Snapshot
Ligand Pharmaceuticals, Inc. Overview
Key Information
Key Facts
Ligand Pharmaceuticals, Inc. - Research and Development Overview
Key Therapeutic Areas
Ligand Pharmaceuticals, Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Partnered Products
Partnered Products/Combination Treatment Modalities
Pipeline Products - Out-Licensed Products
Out-Licensed Products/Combination Treatment Modalities
Ligand Pharmaceuticals, Inc. - Pipeline Products Glance
Ligand Pharmaceuticals, Inc. - Late Stage Pipeline Products
Pre-Registration Products/Combination Treatment Modalities
Phase III Products/Combination Treatment Modalities
Ligand Pharmaceuticals, Inc. - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Ligand Pharmaceuticals, Inc. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Ligand Pharmaceuticals, Inc. - Drug Profiles
lasofoxifene tartrate
Product Description
Mechanism of Action
R&D Progress
clopidogrel bisulfate
Product Description
Mechanism of Action
R&D Progress
aplindore fumarate
Product Description
Mechanism of Action
R&D Progress
pradefovir mesylate
Product Description
Mechanism of Action
R&D Progress
MB-07133
Product Description
Mechanism of Action
R&D Progress
LGD-6972
Product Description
Mechanism of Action
R&D Progress
Drug to Inhibit JAK3 for Inflammation
Product Description
Mechanism of Action
R&D Progress
LG-7455
Product Description
Mechanism of Action
R&D Progress
LGD-3437
Product Description
Mechanism of Action
R&D Progress
LGD-7501
Product Description
Mechanism of Action
R&D Progress
PS-031291
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Antagonize CCR1 for Oncology
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Antagonize CRTH2 for Inflammation and Respiratory Diseases
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Activate Glucokinase for Type 2 Diabetes
Product Description
Mechanism of Action
R&D Progress
Ligand Pharmaceuticals, Inc. - Pipeline Analysis
Ligand Pharmaceuticals, Inc. - Pipeline Products by Target
Ligand Pharmaceuticals, Inc. - Pipeline Products by Route of Administration
Ligand Pharmaceuticals, Inc. - Pipeline Products by Molecule Type
Ligand Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action
Ligand Pharmaceuticals, Inc. - Recent Pipeline Updates
Ligand Pharmaceuticals, Inc. - Dormant Projects
Ligand Pharmaceuticals, Inc. - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
adipiplon
clopidogrel bisulfate
LGD-5552
managlinat dialanetil
NGD-2000-1
NGD-91-1
NGD-91-2
NGD-91-3
NGD-94-1
NGD-94-4
NGD-96-1
NGD-97-1
Vanilloid Receptor-1 Program
Ligand Pharmaceuticals, Inc. - Company Statement
Ligand Pharmaceuticals, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Ligand Pharmaceuticals, Inc., Key Information
Ligand Pharmaceuticals, Inc., Key Facts
Ligand Pharmaceuticals, Inc. - Pipeline by Indication, 2016
Ligand Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2016
Ligand Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2016
Ligand Pharmaceuticals, Inc. - Partnered Products in Pipeline, 2016
Ligand Pharmaceuticals, Inc. - Partnered Products/ Combination Treatment Modalities, 2016
Ligand Pharmaceuticals, Inc. - Out-Licensed Products in Pipeline, 2016
Ligand Pharmaceuticals, Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2016
Ligand Pharmaceuticals, Inc. - Pre-Registration, 2016
Ligand Pharmaceuticals, Inc. - Phase III, 2016
Ligand Pharmaceuticals, Inc. - Phase II, 2016
Ligand Pharmaceuticals, Inc. - Phase I, 2016
Ligand Pharmaceuticals, Inc. - Preclinical, 2016
Ligand Pharmaceuticals, Inc. - Pipeline by Target, 2016
Ligand Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2016
Ligand Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2016
Ligand Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2016
Ligand Pharmaceuticals, Inc. - Recent Pipeline Updates, 2016
Ligand Pharmaceuticals, Inc. - Dormant Developmental Projects,2016
Ligand Pharmaceuticals, Inc. - Discontinued Pipeline Products, 2016
Ligand Pharmaceuticals, Inc., Subsidiaries
List of Figures
Ligand Pharmaceuticals, Inc. - Pipeline by Top 10 Indication, 2016
Ligand Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2016
Ligand Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2016
Ligand Pharmaceuticals, Inc. - Partnered Products in Pipeline, 2016
Ligand Pharmaceuticals, Inc. - Out-Licensed Products in Pipeline, 2016
Ligand Pharmaceuticals, Inc. - Pipeline by Top 10 Target, 2016
Ligand Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2016
Ligand Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2016
Ligand Pharmaceuticals, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report